open access

Vol 65, No 3 (2014)
Original papers
Published online: 2014-06-27
Submitted: 2014-06-27
Accepted: 2014-06-27
Get Citation

Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients

Katarzyna Siewko, Anna Popławska-Kita, Beata Telejko, Rafał Maciulewski, Anna Zielińska, Agnieszka Nikołajuk, Maria Górska, Małgorzata Szelachowska
DOI: 10.5603/EP.2014.0024
·
Endokrynologia Polska 2014;65(3):176-180.

open access

Vol 65, No 3 (2014)
Original papers
Published online: 2014-06-27
Submitted: 2014-06-27
Accepted: 2014-06-27

Abstract

Introduction: The aim of this study was to evaluate beta-cell function and insulin resistance in relation to the occurrence of anti-islet antibodies in first degree relatives of patients with type 1 diabetes (T1D).

Material and methods: The group studied consisted of 90 relatives and 60 healthy individuals without a family history of diabetes. An intravenous glucose tolerance test (IVGTT) was performed in all participants and the first phase insulin response index (FPIR) was calculated. Serum concentrations of GADA, IAA and IA-2A were measured by RIA. HOMA-IR and HOMA%B indices were calculated usinga computer calculator from website.

Results: At least one positive antibody was found in 28 relatives (31.1%) but in none of the controls. The most frequently detected antibodieswere IAA (22.2%). The relatives of diabetic patients had significantly higher fasting insulin level (p), significantly lower FPIR index(p), as well as higher HOMA-IR (p) and lower HOMA%B (p) compared to the controls. A positive correlation between IAA concentration and HOMA-IR (r = 0.287, p < 0.005) and a negative correlation between IAA level and HOMA%B (r = –0.226, p < 0.05) were also shown.

Conclusions: Our results confirmed that more than 30% of the first-degree relatives of diabetic patients have positive markers of autoimmunebeta-cell destruction. The study showed also that these individuals, in spite of normal glucose tolerance, have markedly decreased beta-cell secretory reserve and decreased sensitivity to insulin action, strongly suggesting an increased risk for developing diabetes laterin life.

Abstract

Introduction: The aim of this study was to evaluate beta-cell function and insulin resistance in relation to the occurrence of anti-islet antibodies in first degree relatives of patients with type 1 diabetes (T1D).

Material and methods: The group studied consisted of 90 relatives and 60 healthy individuals without a family history of diabetes. An intravenous glucose tolerance test (IVGTT) was performed in all participants and the first phase insulin response index (FPIR) was calculated. Serum concentrations of GADA, IAA and IA-2A were measured by RIA. HOMA-IR and HOMA%B indices were calculated usinga computer calculator from website.

Results: At least one positive antibody was found in 28 relatives (31.1%) but in none of the controls. The most frequently detected antibodieswere IAA (22.2%). The relatives of diabetic patients had significantly higher fasting insulin level (p), significantly lower FPIR index(p), as well as higher HOMA-IR (p) and lower HOMA%B (p) compared to the controls. A positive correlation between IAA concentration and HOMA-IR (r = 0.287, p < 0.005) and a negative correlation between IAA level and HOMA%B (r = –0.226, p < 0.05) were also shown.

Conclusions: Our results confirmed that more than 30% of the first-degree relatives of diabetic patients have positive markers of autoimmunebeta-cell destruction. The study showed also that these individuals, in spite of normal glucose tolerance, have markedly decreased beta-cell secretory reserve and decreased sensitivity to insulin action, strongly suggesting an increased risk for developing diabetes laterin life.

Get Citation

Keywords

type 1 diabetes; autoantibodies; first-phase insulin secretion; HOMA-IR; HOMA%B

About this article
Title

Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients

Journal

Endokrynologia Polska

Issue

Vol 65, No 3 (2014)

Pages

176-180

Published online

2014-06-27

DOI

10.5603/EP.2014.0024

Bibliographic record

Endokrynologia Polska 2014;65(3):176-180.

Keywords

type 1 diabetes
autoantibodies
first-phase insulin secretion
HOMA-IR
HOMA%B

Authors

Katarzyna Siewko
Anna Popławska-Kita
Beata Telejko
Rafał Maciulewski
Anna Zielińska
Agnieszka Nikołajuk
Maria Górska
Małgorzata Szelachowska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl